Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-046926
Filing Date
2011-08-15
Accepted
2011-08-15 14:02:29
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v231557_10q.htm 10-Q 551758
2 EXHIBIT 31.1 v231557_ex31-1.htm EX-31.1 15372
3 EXHIBIT 31.2 v231557_ex31-2.htm EX-31.2 15677
4 EXHIBIT 32.1 v231557_ex32-1.htm EX-32.1 9701
  Complete submission text file 0001144204-11-046926.txt   2049985

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ck0001341293-20110630.xml EX-101.INS 222666
6 XBRL TAXONOMY EXTENSION SCHEMA ck0001341293-20110630.xsd EX-101.SCH 12954
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001341293-20110630_cal.xml EX-101.CAL 36444
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001341293-20110630_def.xml EX-101.DEF 80431
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001341293-20110630_lab.xml EX-101.LAB 90618
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001341293-20110630_pre.xml EX-101.PRE 87660
Mailing Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021
Business Address 445 NORTHERN BLVD STE 24 GREAT NECK NY 11021 516-482-1200
Neogenix Oncology Inc (Filer) CIK: 0001341293 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD
Type: 10-Q | Act: 34 | File No.: 000-53963 | Film No.: 111035057
SIC: 2835 In Vitro & In Vivo Diagnostic Substances